Centro Studi GISED


Vai ai contenuti
Cambia lingua  IT EN

Pubblicazioni in ambito GISED

Cosa facciamo

Progetti coordinati nell’ambito del Gruppo Italiano Studi Epidemiologici in Dermatologia

Davila-Seijo P, Garcia-Doval I, Naldi L, et al.
Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries. Acta Derm Venereol. 2016 Nov 24.

Garcia-Doval I, Cohen AD, Cazzaniga S, et al.
Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti-tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries. J Am Acad Dermatol. 2016;pii:S0190-9622(16)30590-4.

Cazzaniga S, Castelli E, Di Landro A et al.
Development of a teledermatology system for the melanoma diagnosis. The pilot experience of the project Clicca il neo. Recenti Prog Med. 2016;107:440-3.

Di Landro A, Cazzaniga S, Cusano F, et al. Group for Epidemiologic Research in Dermatology Acne Study Group.
Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy. J Am Acad Dermatol. 2016 Aug 16.

Virgili A, Borghi A, Cazzaniga S,et al.; GLS Italian Study Group.
New insights into potential risk factors and associations in genital lichen sclerosus: Data from a multicentre Italian study on 729 consecutive cases. J Eur Acad Dermatol Venereol. 2016 Aug 12.

Bettoli V, Pasquinucci S, Caracciolo S, et al.
The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities. J Eur Acad Dermatol Venereol. 2016;30:1965-1970.

Naldi L.
Conflicts of interest among academic dermatologists: freedom or constraint? Br J Dermatol. 2016;174:878-80.

Naldi L.
[Italy of miracles. Does the renaissaince of Italian science pass by the Vatican?]. Recenti Prog Med. 2016;107:117-20.

Naldi L, Cazzaniga S.
Author's Reply to the Response to the Commentary of Naldi and Cazzaniga Entitled 'Are All Screening Programmes Created Equal? The Case of Melanoma'. Dermatology. 2016 Apr 7. [Epub ahead of print]

Turati F, Bertuccio P, Galeone C, et al; HYGIENE Study Group.
Early weaning is beneficial to prevent atopic dermatitis occurrence in young children. Allergy. 2016 Feb 19. [Epub ahead of print]

Naldi L, Cazzaniga S.
Prediction of high total naevus count to estimate melanoma risk. We need more, don't we? Br J Dermatol. 2016;174:261-2.

Diepgen TL, Naldi L, Bruze M, et al.
Prevalence of Contact Allergy to p-Phenylenediamine in the European General Population. J Invest Dermatol. 2016;136:409-15.

Diphoorn J, Cazzaniga S, Gamba C, et al.
Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Pharmacoepidemiol Drug Saf. 2015 Dec 21. [Epub ahead of print]

Ofenloch R, Diepgen TL, Bruze M, et al.
Colophony as marker for fragrance allergy in the general European population. Br J Dermatol. 2015 Nov 19. [Epub ahead of print]

Naldi L, Cazzaniga S.
Are All Screening Programmes Created Equal? The Case of Melanoma. Dermatology. 2015 Sep 26. [Epub ahead of print]

Diepgen TL, Ofenloch R, Bruze M, et
al. Prevalence of contact allergy in the general population in different European regions. Br J Dermatol. 2015 Sep 15. [Epub ahead of print]

Diepgen TL, Ofenloch R, Bruze M, et al.
Prevalence of fragrance contact allergy in the general population of five European countries - a cross-sectional study. Br J Dermatol. 2015 Sep 2. [Epub ahead of print]

Naldi L, Diphoorn J.
Seborrhoeic dermatitis of the scalp. BMJ Clin Evid. 2015 May 27. [Epub ahead of print]

Bettoli V, Naldi L, Cazzaniga S, et al.
Overweight diabetes and disease duration influence clinical severity in Hidradenitis Suppurativa - Acne Inversa. Evidence from the national Italian Registry. Br J Dermatol. 2015 Apr 27. [Epub ahead of print]

Naldi L.
Melanoma excision: how deep must we go? Br J Dermatol. 2014 Dec;171(6):1291-2.

Cazzaniga S, Lecchi S, Bruze M, et al.
Development of a clinical score system for the diagnosis of photoallergic contact dermatitis using a consensus process: item selection and reliability. J Eur Acad Dermatol Venereol. 2014 Dec 3. [Epub ahead of print]

Grossi E, Cazzaniga S, Crotti S, et al.
The constellation of dietary factors in adolescent acne: a semantic connectivity map approach. J Eur Acad Dermatol Venereol. 2014 Dec 2. [Epub ahead of print]

Naldi L.
[Free drug samples for doctors? No, thank you!]. Recenti Prog Med. 2014;105:403-4.

Naldi L.
Lifestyle intervention should be an essential component of medical care for skin disease: a challenging task. Br J Dermatol. 2014;171:934-5.

Gisondi P, Cazzaniga S, Chimenti S, et al.
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry. Br J Dermatol. 2014 Nov 17. [Epub ahead of print]

Ingordo V, Cazzaniga S, Medri M, et al.
To What Extent Is Quality of Life Impaired in Vitiligo? A Multicenter Study on Italian Patients Using the Dermatology Life Quality Index. Dermatology. 2014 Oct 25. [Epub ahead of print]

Gamba C, Schroeder J, Citterio A, et al.
[Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia]. Recenti Prog Med. 2014;105:379-84.

Cazzaniga S, Conti A, Naldi L; Psoriasis Emilia Romagna Study Group.
Comments on "Diet and psoriasis, part I: Impact of weight loss interventions". J Am Acad Dermatol. 2014;71:829.

Parlar B, Blazek C, Cazzaniga S, Naldi L, et al.
Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. J Eur Acad Dermatol Venereol. 2014 Jul 28. [Epub ahead of print]

Naldi L, Crotti S.
Epidemiology of cutaneous drug-induced reactions. G Ital Dermatol Venereol. 2014;149:207-18.

Naldi L, Conti A, Cazzaniga S, et al; the Psoriasis Emilia Romagna Study Group.
Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol. 2014;170:634–642.

Ingordo V, Cazzaniga S, Raone B, et al.
Circulating Autoantibodies and Autoimmune Comorbidities in Vitiligo Patients: A Multicenter Italian Study. Dermatology. 2014 Mar 5. [Epub ahead of print]

Bencini PL, Cazzaniga S, Galimberti MG, Zane C, Naldi L.
Variables affecting clinical response to treatment of facial port-wine stains by flash lamp-pumped pulsed dye laser: the importance of looking beyond the skin. Lasers Med Sci. 2014 Feb 1. [Epub ahead of print]

Cazzaniga S, Lo Scocco G, Schincaglia E, et al.
Randomized, Within-Patient, Clinical Trial Comparing Fluorine-Synthetic Fiber Socks with Standard Cotton Socks in Improving Plantar Pustulosis. Dermatology. 2014 Jan 9. [Epub ahead of print]

Naldi L, Cazzaniga S, Gonçalo M, et al; for the EDEN Fragrance Study Group.
Prevalence of Self-reported Skin Complaints and Avoidance of Common Daily Life Consumer Products in Selected European Regions. JAMA Dermatol. 2013 Dec 25. [Epub ahead of print]

Piaserico S, Cazzaniga S, Chimenti S, et al.
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry. J Am Acad Dermatol. 2013 Dec 16. [Epub ahead of print]

Parazzini F, Cipriani S, Zinetti C, et al.
Perinatal factors and the risk of atopic dermatitis: A cohort study. Pediatr Allergy Immunol. 2013 Dec 9. (Epub ahead of print).

Ortonne JP, Esposito M, Chimenti S, et al.
Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial. J Eur Acad Dermatol Venereol. 2013 Oct 29 (Epub ahead of print).

Naldi L, Cazzaniga S. [
Dermatology: experience with the disease registry for the treatment of psoriasis]. Recenti Prog Med. 2013 Jun;104(6):236-40.

Naldi L, Lecchi S.
Floating numerators on photopatch tests: how to interpret them? Br J Dermatol. 2013 Jun 18. [Epub ahead of print]

Naldi L.
Melanoma management in Italy: learning from practice. A survey from the intergruppo italiano melanoma. Dermatology. 2013;226 Suppl 1:IV.

Garcia-Doval I, Rustenbach SJ, Stern R, et al. The Psonet Network.
Systemic psoriasis therapy shows high between-countries variation. A sign of unwarranted variation? Cross-sectional analysis of baseline data from the Psonet registries. Br J Dermatol. 2013 Mar 29.

Naldi L.
Risk Factors for Psoriasis. Curr Dermatol Rep. 2013;2:58-65.

Calzavara-Pinton PG, Rossi MT, Piovanelli P, Naldi L.
The main organizational changes in dermatological practice in the Lombardy Region, Italy, from 2001 to 2009. J Eur Acad Dermatol Venereol. 2013;27:206-213.

Tessari G, Naldi L, Boschiero L, et al.
Incidence of Primary and Second Cancers in Renal Transplant Recipients: A Multicenter Cohort Study. Am J Transplant. 2012 Oct 11.

Tabolli S, Naldi L, Pagliarello et al. The Italian Writing Exercise Study Group.
Evaluation of the impact of writing exercises interventions on quality of life in patients with psoriasis undergoing systemic treatments. Br J Dermatol. 2012 Sep 27.

Raho G, Koleva DM, Garattini L, Naldi L.
The Burden of Moderate to Severe Psoriasis: An Overview. Pharmacoeconomics. 2012 Sep 20.

Bencini PL, Cazzaniga S, Tourlaki A, et al.
Removal of Tattoos by Q-Switched Laser: Variables Influencing Outcome and Sequelae in a Large Cohort of Treated Patients. Arch Dermatol. 2012 Sep 17:1-7 [Epub ahead of print]

Cazzaniga S, Scocco GL, Schincaglia E, et al.
Double-blind, Within-patient, Randomized, Clinical Trial Comparing Fluorine-Synthetic Fiber Socks With Standard Cotton Socks in Improving PlantarPsoriasis. J Dermatolog Treat. 2012 Mar 29. [Epub ahead of print]

Di Landro A, Cazzaniga S, Parazzini F,et al; GISED Acne Study Group.
Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol. 2012 Feb 29. [Epub ahead of print]

Suppa M, Cazzaniga S, Fargnoli MC, et al.
Knowledge, perceptions and behaviours about skin cancer and sun protection among secondary school students from Central Italy. J Eur Acad Dermatol Venereol. 2012 Feb 20.

Ingordo V, Cazzaniga S, Gentile C, et al.
Dermatology Life Quality Index score in vitiligo patients: a pilot study among young Italian males. G Ital Dermatol Venereol. 2012;147:83-90.

Gisondi P, Cazzaniga S, Chimenti S, et al.; Psocare Study Group.
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. J Eur Acad Dermatol Venereol. 2012 Feb 7.

Rovelli F, Mercuri SR, Naldi L.
Seborrheic dermatitis in clinical practice. Recenti Prog Med. 2011;102:126-133.

Naldi L, Yawalkar N, Kaszuba A, et al.
Efficacy and Safety of the Betamethasone Valerate 0.1% Plaster in Mild-to-Moderate Chronic Plaque Psoriasis: A Randomized, Parallel-Group, Active-Controlled, Phase III Study. Am J Clin Dermatol. 2011 Jan 29.

Rossi M, Coenraads PJ, Diepgen T, et al.
Design and Feasibility of an International Study Assessing the Prevalence of Contact Allergy to Fragrances in the General Population: The European Dermato-Epidemiology Network Fragrance Study. Dermatology. 2010 Sep 25. [Epub ahead of print]

Naldi L, Mercuri SR.
Chronic Pruritus Management: A Plea for Improvement - Can Itch Clinics Be an Option? Dermatology. 2010 Sep 7. [Epub ahead of print]

Gialloreti LE, Merito M, Pezzotti P, Naldi L, et al.
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:230.

Mercuri SR, Naldi L.
Potential role of ustekinumab in the treatment of chronic plaque psoriasis. Biologics. 2010;4:119-29.

Naldi L, Mercuri SR.
Epidemiology of comorbidities in psoriasis. Dermatol Ther. 2010;23:114-8.

Ingordo V, Gentile C, Iannazzone S, et al.
Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males. J Eur Acad Dermatol Venereol. 2010 May 7. [Epub ahead of print]

Naldi L.
How to evaluate the benefit-risk profile of newly marketed drugs. Ann Dermatol Venereol. 2010;137:264-6.

Begnini A, Tessari G, Turco A, et al.
PTCH1 gene haplotype association with basal cell carcinoma after transplantation. Br J Dermatol. 2010 Mar 23. [Epub ahead of print]

Tessari G, Naldi L, Boschiero L, et al.
Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Arch Dermatol. 2010;146:294-9.

Naldi L.
Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies. Clin Dermatol. 2010 Jan;28(1):88-92.

Naldi L.
Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies. Clin Dermatol. 2010 Jan;28(1):67-72.

Naldi L, Mercuri SR.
Smoking and psoriasis: from epidemiology to pathomechanisms. J Invest Dermatol. 2009;129:2741-3.

Naldi L, Svensson A, Zenoni D, et al.; on behalf of the European Dermato-Epidemiology Network (EDEN).
Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis. Update of the EDEN Psoriasis Survey 2001-2006. Br J Dermatol. 2009 Sep 24. [Epub ahead of print]

Naldi L.
Should we use body mass index to predict disease onset and severity in psoriasis? Acta Derm Venereol. 2009;89(5):452.

Pathirana D, Ormerod A, Saiag P, et al.
European S3-Guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;23(s2):1-70.

Tessari G, Naldi L, Piaserico S, et al.
Incidence and clinical predictors of primary opportunistic deep cutaneous mycoses in solid organ transplant recipients: a multicenter cohort study. Clin Transplant. 2009 Aug 27.

Cazzaniga S, Sassi F, Mercuri SR et al.
Prediction of Clinical Response to Excimer Laser Treatment in Vitiligo by Using Neural Network Models. Dermatology. 2009 Jun 18.

Naldi L, Rzany B.
Psoriasis (chronic plaque). Clin Evid (Online). 2009 Jan 9;2009. pii: 1706.

Naldi L, Sassi F.
Evaluation of patient education. Cancer Treat Res. 2009;146:417-23.

Naldi L, Parazzini F, Gallus S; GISED Study Centres.
Prevalence of atopic dermatitis in italian schoolchildren: factors affecting its variation. Acta Derm Venereol. 2009;89:122-5.

Naldi L, Chatenoud L.
Registry research in dermatology. Dermatol Clin. 2009; 27:185-91.

Naldi L, Raho G.
Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Feb 27. [Epub ahead of print]

Gallus S, Naldi L.
Longitudinal Studies of Melanocytic Nevi in Children: A Clue to Improve Understanding of Melanoma in Adults. Arch Dermatol 2009;145 191-193 (editorial)

Naldi L, Rebora A.
Seborrheic Dermatitis. N Engl J Med. 2009;360:387-396.

Lecluse LL, Naldi L, Stern RS, et al.
National Registries of Systemic Treatment for Psoriasis and the European 'Psonet' Initiative. Dermatology. 2008 Dec 11. [Epub ahead of print]

Merito M, Largeron N, Cohet C, et al.
Treatment patterns and associated costs for genital warts in Italy. Curr Med Res Opin. 2008 Oct 10. [Epub ahead of print]

Naldi L, Addis A, Chimenti S, Giannetti A, et al
Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis. Evidence from the Psocare Project. Dermatology. 2008 Sep 23;217:365-373. [Epub ahead of print]

Sassi F, Cazzaniga S, Tessari G, Chatenoud L, Reseghetti A, Marchesi L, Girolomoni G, Naldi L.
Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. Br J Dermatol. 2008 Aug 19. [Epub ahead of print]

Ingordo V, Iannazzone SS, Cusano F, Naldi L.
Reproducibility of Dermoscopic Features of Congenital Melanocytic Nevi. Dermatology. 2008 Jul 25;217:231-234. [Epub ahead of print]

Gallus S, Naldi L; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology.
Distribution of congenital melanocytic naevi and congenital naevus-like naevi in a survey of 3406 Italian schoolchildren. Br J Dermatol. 2008;159:433-8.

Naldi L.
Assessment of the risk of fragrance allergy in the general population: challenges and methodological issues. Drug Saf. 2008;31:440-3

Naldi L, Chatenoud L, Belloni A, etal.
Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology. 2008;216:125-30; discussion 130-2.

Pelucchi C, Naldi L, Di Landro A, et al.
Anthropometric Measures, Medical History and Risk of Basal Cell Carcinoma in an Italian Case-Control Study. Dermatology. 2008; 216:271-276 [Epub ahead of print]

Lonjou C, Borot N, Sekula P, et al; for the RegiSCAR study group.
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics. 2008; 18:99-107.

Mockenhaupt M, Viboud C, Dunant A, et al.
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study. J Invest Dermatol. 2008; 128:35-44.

Halevy S, Ghislain PD, Mockenhaupt M, et al; for the EuroSCAR Study Group.
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol. 2008; 58:25-32.

Naldi L, Gambini D.
The clinical spectrum of psoriasis. Clin Dermatol. 2007; 25:510-8.

Sidoroff A, Dunant A, Viboud C, et al.
Risk factors for acute generalized exanthematous pustulosis (AGEP) - results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007; 157:989-96.

Gallus S, Naldi L, Carli P, et al; Italian Group for Epidemiologic Research in Dermatology (GISED).
Nevus count on specific anatomic sites as a predictor of total body count: a survey of 3,406 children from Italy. Am J Epidemiol. 2007; 166:472-8.

Naldi L, Chatenoud L, Bertuccio P, et al.
Improving Sun-Protection Behavior among Children: Results of a Cluster-Randomized Trial in Italian Elementary Schools. The "SoleSi SoleNo-GISED" Project. J Invest Dermatol. 2007; 127:1871-7.

Ingordo V, Gentile C, Iannazzone SS, et al.
Congenital melanocytic nevus: an epidemiologic study in Italy. Dermatology. 2007; 214:227-30.

Pelucchi C, Di Landro A, Naldi L, et al; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED).
Risk factors for histological types and anatomic sites of cutaneous basal-cell carcinoma: an italian case-control study. J Invest Dermatol. 2007; 127:935-44.

Naldi L, Chatenoud L, Piccitto R, et al; Prevalence of Actinic Keratoses Italian Study (PraKtis) Group.
Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: Results from the Prevalence of Actinic Keratoses Italian Study, 2003-2004. Arch Dermatol. 2006; 142:722-6.

Naldi L, Randi G, Di Landro A, et al.
Red hairs, number of nevi, and risk of cutaneous malignant melanoma: results from a case-control study in Italy. Arch Dermatol. 2006; 142:935-6.

Ingordo V, Iannazzone SS, Cusano F, et al.
Dermoscopic features of congenital melanocytic nevus and Becker nevus in an adult male population: an analysis with a 10-fold magnification. Dermatology. 2006; 212:354-60.

Randi G, Naldi L, Gallus S, et al; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED).
Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J Invest Dermatol. 2006; 126:2106-10.

Gallus S, Naldi L, Martin L, et al; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED).
Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res. 2006; 16:83-7.

Naldi L, Altieri A, Imberti GL, et al; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology.
Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control. 2005; 16:893-9.

Naldi L, Altieri A, Imberti GL, et al; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED).
Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol. 2005;15:545-50.

Naldi L, Chatenoud L, Linder D, et al.
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61-7.

Naldi L, Gallus S, Tavani A, et al; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology.
Risk of melanoma and vitamin A, coffee and alcohol: a case-control study from Italy. Eur J Cancer Prev. 2004;13:503-8.

Naldi L, Colombo P, Placchesi EB, et al; PraKtis Study Centers.
Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology. 2004;208:38-42.

Oncology Cooperative Group Of The Italian Group For Epidemiologic Research In Dermatology (GISED).
Improving sun protection behaviour in children: study design and baseline results of a randomized trial in Italian elementary schools. The 'Sole Si Sole No GISED' project. Dermatology. 2003;207:291-7.

Carli P, Naldi L, Lovati S, et al. Oncology Cooperative Group of the Italian Group for Epidemiologic Research in Dermatology (GISED).
The density of melanocytic nevi correlates with constitutional variables and history of sunburns: a prevalence study among Italian schoolchildren. Int J Cancer. 2002;101:375-9.

Auquier-Dunant A, Mockenhaupt M, Naldi L, et al; SCAR Study Group.
Severe Cutaneous Adverse Reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138:1019-24.

Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, et al; EuroSCAR Study Group.
Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS. 2001;15:1843-8.

Naldi L, Peli L, Parazzini F, et al; Psoriasis Study Group of the Italian Group for Epidemiological Research in Dermatology.
Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol. 2001;44:433-8.

Naldi L, Fortina AB, Lovati S, et al.
Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation. 2000;70:1479-84.

Naldi L, Lorenzo Imberti G, Parazzini F, et al.
Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer. 2000;88:2703-10.

Naldi L, Gallus S, Imberti GL, et al.
Sunscreens and cutaneous malignant melanoma: an Italian case-control study. Int J Cancer. 2000;86:879-82.

Naldi L, Gallus S, Imberti GL, et al.
Sunlamps and sunbeds and the risk of cutaneous melanoma. Italian Group for Epidemiological Research in Dermatology. Eur J Cancer Prev. 2000;9:133-4.

Naldi L, DiLandro A, D'Avanzo B, et al.
Host-related and environmental risk factors for cutaneous basal cell carcinoma: evidence from an Italian case-control study. J Am Acad Dermatol. 2000;42:446-52.

Naldi L, Peli L, Parazzini F.
Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol. 1999;135:1479-84.

Rzany B, Correia O, Kelly JP, et al. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.
Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Lancet. 1999;353:2190-4.

L. Naldi, C. Ferri. Gruppo Italiano Studi Epidemiologici in Dermatologia.
Cutaneous reactions to alimentary tract medications: results of a seven-year surveillance program and review of the literature. Dermatology.1996;193:11-6.

Naldi L, Parazzini F, Peli L, et al.
Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br J Dermatol. 1996;134:101-6.

Roujeau JC, Kelly JP, Naldi L, et al.
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-7.

Kelly JP, Auquier A, Rzany B, et al.
An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol. 1995;48:1099-108.

L. Naldi, T. Cainelli. Gruppo Italiano Studi Epidemiologici in Dermatologia.
Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia. Dermatology. 1993;186:164-9.

Naldi L, Bertoni M, Cainelli T. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED).
Feasibility of a registry of pemphigus in Italy: two years experience. Int J Dermatol. 1993;32:424-7.

Ferri C, Reseghetti A, Veraldi S, et al.
Bamifylline induced exanthema. Ann Dermatol Venereol.1991;118:635-6.

Naldi L, Sena P, Cainelli T.
About the association of lichen planus and psoriasis. Dermatologica. 1990;181:79-80.

Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED).
Lichen planus and liver diseases: a multicentre case-control study. BMJ. 1990;300:227-30.

Naldi L.
The Italian Group for Epidemiological Studies in Dermatology and the pilot project on the etiology of lichen planus. G Ital Dermatol Venereol. 1987;122:77-83.


Aggiornato il 28 nov 2016  -  Centro Studi GISED  P.I. 02274270988 | Condizioni d'uso    Privacy    Credits

Torna ai contenuti | Torna al menu
Facebook Twitter Google+ LinkedIn Email